“Beyond Benzodiazepines: Alternative Management of Alcohol Withdrawal Syndrome in the ICU Population”
Event Navigation
Download a copy of this content.
Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.
HealthTrust presents…”Beyond Benzodiazepines: Alternative Management of Alcohol Withdrawal Syndrome in the ICU Population”
The current mainstay of treatment for acute alcohol withdrawal syndrome is benzodiazepines. In critically ill patients, benzodiazepines pose specific challenges such as tolerance which leads to increased dosing requirements and potential for adverse events. Additionally, benzodiazepines have been shown in critical care clinical studies to negatively impact patient outcomes. During this session, the presenter will begin with an overview of alcohol withdrawal syndrome (AWS) including pathophysiology and a disease progression timeline. Current recommendations and typical management of alcohol withdrawal syndrome as well as the limitations that exist with the current state of practice will also be discussed. A review of the current literature with an emphasis on the critically ill patient population and the potential role of nonbenzodiazepine pharmacologic therapy in AWS will also be provided.
Learning Objectives for Nurses & Pharmacists | At the end of this session, participants should be able to…
- Identify limitations of benzodiazepine therapy for the management of alcohol withdrawal syndrome (AWS).
- Describe outcomes found in literature to support the use of alternative agents for AWS.
- Classify therapeutic options for AWS by level of available evidence.
Learning Objectives for Pharmacy Technicians | At the end of this session, participants should be able to…
- List the common signs and symptoms of alcohol withdrawal syndrome.
- Identify agents that have been studied as alternatives to benzodiazepines.
Presenter:
Angelica Tarnawski, PharmD | PGY-1 Pharmacy Resident | Atlantic Health System
Target Audience: Nurses, Pharmacists & Pharmacy Technicians
Continuing Education Information: 1.0 contact hour approved for Nurses, Pharmacists & Pharmacy Techs. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-20-067-L01-P and 0863-9999-20-067-L01-T. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for Nurses, Pharmacists and Pharmacy Techs who attend the webinar and complete the online evaluation.
California Board of Registered Nursing Approval. Pfiedler is a provider approved by the California Board of Registered Nursing, Provider Number CEP 14944 for 1.0 contact hour.
Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the entire webinar in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net. A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
